Deprescribing in the Pharmacologic Management of Delirium: A Randomized Trial in the Intensive Care Unit

Journal of the American Geriatrics Society

Fecha de publicación: 21 January 2019


Autores: Noll L. Campbell PharmD, MS., Anthony J. Perkins MS., Babar A. Khan MD, MS., Sujuan Gao PhD., Mark O. Farber MD., Sikandar Khan MD, MS.

Background: Benzodiazepines and anticholinergics are risk factors for delirium in the intensive care unit (ICU). We tested the impact of a deprescribing intervention on short‐term delirium outcomes.

Seguir leyendo

Enviar comentario